HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Venkataraman Amarnath Selected Research

isolevuglandin

1/2022Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.
1/2021Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis.
1/2021Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction.
1/2021Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
1/2019Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
1/2019Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
6/2015Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Venkataraman Amarnath Research Topics

Disease

8Inflammation (Inflammations)
01/2021 - 12/2006
6Hypertension (High Blood Pressure)
01/2022 - 10/2014
5Atherosclerosis
01/2021 - 04/2009
4Neoplasms (Cancer)
01/2021 - 11/2009
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2003
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2020 - 06/2015
2Carcinogenesis
01/2021 - 04/2014
2Heart Failure
01/2021 - 01/2019
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 01/2003
2Ischemia
11/2007 - 12/2005
2Parkinsonian Disorders (Parkinsonism)
01/2003 - 12/2002
2Parkinson Disease (Parkinson's Disease)
01/2003 - 12/2002
1Carcinoma (Carcinomatosis)
01/2021
1Colitis
01/2021
1Gastritis
01/2021
1Metaplasia
01/2021
1Essential Hypertension
12/2020
1Atrial Fibrillation
06/2020
1Cognitive Dysfunction
01/2020
1Infections
10/2019
1Sepsis (Septicemia)
01/2019
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Diabetes Complications
07/2015
1Obesity
06/2015
1Amyloidosis
02/2015
1Body Weight (Weight, Body)
01/2011
1Cardiovascular Diseases (Cardiovascular Disease)
05/2010
1Thrombosis (Thrombus)
04/2009
1Demyelinating Diseases (Demyelinating Disease)
02/2006
1Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2005
1Colorectal Neoplasms (Colorectal Cancer)
04/2004
1Wounds and Injuries (Trauma)
01/2002

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2010
7isolevuglandinIBA
01/2022 - 06/2015
42-(aminomethyl)phenolIBA
01/2020 - 01/2019
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 12/2005
3LipidsIBA
06/2020 - 09/2012
3Lysine (L-Lysine)FDA Link
12/2019 - 10/2015
34-hydroxy-2-nonenal (4-hydroxynonenal)IBA
04/2004 - 01/2002
2HDL LipoproteinsIBA
01/2021 - 12/2019
2Superoxides (Superoxide)IBA
12/2020 - 11/2007
2Lipoproteins (Lipoprotein)IBA
01/2020 - 05/2011
2CholesterolIBA
01/2020 - 06/2015
24-oxo-2-nonenalIBA
12/2019 - 10/2015
2PyridoxamineIBA
07/2015 - 12/2006
2Pharmaceutical PreparationsIBA
07/2015 - 12/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2014 - 11/2009
2ManebIBA
01/2003 - 12/2002
2PesticidesIBA
01/2003 - 12/2002
1AntigensIBA
01/2021
1AzoxymethaneIBA
01/2021
1EnzymesIBA
01/2021
1GastrinsIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1Dextran SulfateIBA
01/2021
1DNA AdductsIBA
01/2021
1Aryldialkylphosphatase (Paraoxonase)IBA
01/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2020
1Angiotensin IIIBA
12/2020
1Sirtuin 3IBA
12/2020
1AntioxidantsIBA
06/2020
1LactamsIBA
10/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1CationsIBA
01/2019
1triphenylphosphoniumIBA
01/2019
1LipopolysaccharidesIBA
01/2019
1LigandsIBA
06/2015
1F2-Isoprostanes (F2 Isoprostanes)IBA
10/2014
1Histones (Histone)IBA
04/2014
1Nucleosomes (Nucleosome)IBA
04/2014
1AldehydesIBA
09/2012
1Apolipoprotein E4IBA
01/2011
1Arachidonic Acid (Vitamin F)IBA
04/2009
1Oxygen (Dioxygen)IBA
11/2007
1Oxidants (Oxidizing Agents)IBA
12/2006
1CopperIBA
02/2006
1prolinedithiocarbamate (PDTC)IBA
02/2006
1SodiumIBA
12/2005
1manganese ethylenebis(dithiocarbamate)IBA
01/2003
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
01/2003
1ElementsIBA
01/2003
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
01/2003
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2003
1Dopamine (Intropin)FDA LinkGeneric
01/2003
1ParaquatIBA
12/2002

Therapy/Procedure

1Therapeutics
01/2022
1Chemoprevention
01/2021